Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer
Mingzhu Yin, … , Ge Lou, Wang Min
Mingzhu Yin, … , Ge Lou, Wang Min
Published October 10, 2016
Citation Information: J Clin Invest. 2016;126(11):4157-4173. https://doi.org/10.1172/JCI87252.
View: Text | PDF
Research Article Inflammation Oncology Article has an altmetric score of 65

Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer

  • Text
  • PDF
Abstract

Tumor-associated macrophages (TAMs) can influence ovarian cancer growth, migration, and metastasis, but the detailed mechanisms underlying ovarian cancer metastasis remain unclear. Here, we have shown a strong correlation between TAM-associated spheroids and the clinical pathology of ovarian cancer. Further, we have determined that TAMs promote spheroid formation and tumor growth at early stages of transcoelomic metastasis in an established mouse model for epithelial ovarian cancer. M2 macrophage–like TAMs were localized in the center of spheroids and secreted EGF, which upregulated αMβ2 integrin on TAMs and ICAM-1 on tumor cells to promote association between tumor cells and TAM. Moreover, EGF secreted by TAMs activated EGFR on tumor cells, which in turn upregulated VEGF/VEGFR signaling in surrounding tumor cells to support tumor cell proliferation and migration. Pharmacological blockade of EGFR or antibody neutralization of ICAM-1 in TAMs blunted spheroid formation and ovarian cancer progression in mouse models. These findings suggest that EGF secreted from TAMs plays a critical role in promoting early transcoelomic metastasis of ovarian cancer. As transcoelomic metastasis is also associated with many other cancers, such as pancreatic and colon cancers, our findings uncover a mechanism for TAM-mediated spheroid formation and provide a potential target for the treatment of ovarian cancer and other transcoelomic metastatic cancers.

Authors

Mingzhu Yin, Xia Li, Shu Tan, Huanjiao Jenny Zhou, Weidong Ji, Stefania Bellone, Xiaocao Xu, Haifeng Zhang, Alessandro D. Santin, Ge Lou, Wang Min

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2009 Total
Citations: 13 36 32 40 41 32 17 16 10 1 238
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (238)

Title and authors Publication Year
TAM-derived exosomal miR-589-3p accelerates ovarian cancer progression through BCL2L13
Wang J, Zhu Y, He Y, Shao W
Journal of Ovarian Research 2025
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Guan F, Wang R, Yi Z, Luo P, Liu W, Xie Y, Liu Z, Xia Z, Zhang H, Cheng Q
Signal Transduction and Targeted Therapy 2025
Identifying macrophage-associated subtypes in patients with serous ovarian cancer and exploring potential personalized therapeutic drugs using combined single-cell and bulk RNA sequencing omics
Teng F, Wei H, Che D, Miao K, Dong X
Heliyon 2025
Harnessing Macrophages in Cancer Therapy: from Immune Modulators to Therapeutic Targets
Tan H, Cai M, Wang J, Yu T, Xia H, Zhao H, Zhang X
International Journal of Biological Sciences 2025
ZEB1 promotes the immune escape of ovarian cancer through the MCSF-CCL18 axis
Jin YP, Li GW, Xu QQ, Wang XL
Cancer Cell International 2025
Cross-Talk Between Cancer and Its Cellular Environment—A Role in Cancer Progression
Turlej E, Domaradzka A, Radzka J, Drulis-Fajdasz D, Kulbacka J, Gizak A
Cells 2025
PLIN2 Promotes Lipid Accumulation in Ascites‐Associated Macrophages and Ovarian Cancer Progression by HIF1α/SPP1 Signaling
Luo H, She X, Zhang Y, Xie B, Zhang S, Li Q, Zhou Y, Guo S, Zhang S, Jiang Y, Dong Y, He J, Wang L, Zhang Q, Zhuang Y, Deng P, Wang F, Liu J, Chen X, Nie H, He H
Advanced Science 2025
Hyperinflammatory repolarisation of ovarian cancer patient macrophages by anti-tumour IgE antibody, MOv18, restricts an immunosuppressive macrophage:Treg cell interaction
Osborn G, López-Abente J, Adams R, Laddach R, Grandits M, Bax HJ, Chauhan J, Pellizzari G, Nakamura M, Stavraka C, Chenoweth A, Palhares LC, Evan T, Lim JH, Gross A, Moise L, Jatiani S, Figini M, Bianchini R, Jensen-Jarolim E, Ghosh S, Montes A, Sayasneh A, Kristeleit R, Tsoka S, Spicer J, Josephs DH, Karagiannis SN
Nature Communications 2025
NAT10 Promotes Gastric Cancer Liver Metastasis by Modulation of M2 Macrophage Polarization and Metastatic Tumor Cell Hepatic Adhesion
Chen C, Wang Z, Lin Q, Li M, Xu L, Fu Y, Zhao X, Ma Z, Xu J, Zhou S, Zhang M, Qian Y, Bao L, Wang B, Wang M, Ding Q, Wang Q, Wang S
Advanced Science 2025
Cell Biology of Cancer Peritoneal Metastasis: Multiclonal Seeding and Peritoneal Tumor Microenvironment
Yamaguchi H, Miyazaki M
Cancer Science 2025
Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements.
Wang Y, Zhu N, Liu J, Chen F, Song Y, Ma Y, Yang Z, Wang D
Journal of translational medicine 2025
Significance and mechanisms of perineural invasion in malignant tumors
Wang M, Pu N, Bo X, Chen F, Zhou Y, Cheng Q
Frontiers in Oncology 2025
Unraveling the role of M2 TAMs in ovarian cancer dynamics: a systematic review
Wang Y, Ma C, Li X, Yang F, Wang N, Ji G, Liu Q, Zhu H, Xu S, Li H
Journal of Translational Medicine 2025
Tumor cell-intrinsic MELK enchanced CCL2-dependent immunosuppression to exacerbate hepatocarcinogenesis and confer resistance of HCC to radiotherapy
Bufu Tang, Jinyu Zhu, Yueli Shi, Yajie Wang, Biao Chen, Shiji Fang, Yang Yang, Liyun Zheng, Rongfang Qiu, Qiaoyou Weng, Min Xu, Zhongwei Zhao, Jianfei Tu, Minjiang Chen, Jiansong Ji
Molecular Cancer 2024
Combined BET and MEK Inhibition synergistically suppresses melanoma by targeting YAP1
Hu R, Hou H, Li Y, Zhang M, Li X, Chen Y, Guo Y, Sun H, Zhao S, Liao M, Cao D, Yan Q, Chen X, Yin M
Theranostics 2024
Signatures of tumor-associated macrophages correlate with treatment response in ovarian cancer patients
Gao Y, Qi Y, Shen Y, Zhang Y, Wang D, Su M, Liu X, Wang A, Zhang W, He C, Yang J, Dai M, Wang H, Cai H
Aging 2024
BCLAF1 binds SPOP to stabilize PD-L1 and promotes the development and immune escape of hepatocellular carcinoma
Yu Z, Wu X, Zhu J, Yan H, Li Y, Zhang H, Zhong Y, Lin M, Ye G, Li X, Jin J, Li K, Wang J, Zhuang H, Lin T, He J, Lu C, Xu Z, Zhang X, Li H, Jin X
Cellular and Molecular Life Sciences 2024
Chondroitin Sulfate Proteoglycan 4 Provides New Treatment Approach to Preventing Peritoneal Dissemination in Ovarian Cancer
Uno K, Koya Y, Yoshihara M, Iyoshi S, Kitami K, Sugiyama M, Miyamoto E, Mogi K, Fujimoto H, Yamakita Y, Wang X, Nawa A, Kajiyama H
International journal of molecular sciences 2024
N6-methyladenosine-modified VGLL1 promotes ovarian cancer metastasis through high-mobility group AT-hook 1/Wnt/β-catenin signaling
Li H, Cai L, Pan Q, Jiang X, Zhao J, Xiang T, Tang Y, Wang Q, He J, Weng D, Zhang Y, Liu Z, Xia J
iScience 2024
Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics
Akinsipe T, Mohamedelhassan R, Akinpelu A, Pondugula SR, Mistriotis P, Avila LA, Suryawanshi A
Frontiers in immunology 2024
Regulation of PD-L1 Expression by YY1 in Cancer: Therapeutic Efficacy of Targeting YY1
Dillen A, Bui I, Jung M, Agioti S, Zaravinos A, Bonavida B
Cancers 2024
Navigating tumor angiogenesis: therapeutic perspectives and myeloid cell regulation mechanism.
Yang F, Lee G, Fan Y
Angiogenesis 2024
The dance of macrophage death: the interplay between the inevitable and the microenvironment.
Makuch M, Stepanechko M, Bzowska M
Frontiers in immunology 2024
Crosstalk between cancer cells and macrophages promotes OSCC cell migration and invasion through a CXCL1/EGF positive feedback loop.
Huang W, Jiang M, Lin Y, Qi Y, Li B
Discover. Oncology 2024
The role of tumor-associated macrophages in tumor immune evasion.
Huang R, Kang T, Chen S
Journal of Cancer Research and Clinical Oncology 2024
NGEF is a potential prognostic biomarker and could serve as an indicator for immunotherapy and chemotherapy in lung adenocarcinoma
Chen X, Zhang T, He YQ, Miao TW, Yin J, Ding Q, Yang M, Chen FY, Zeng HP, Liu J, Zhu Q
BMC Pulmonary Medicine 2024
The prognostic implications and tumor-promoting functions of CHSY3 in gastric cancer
Wang H, Zhang J, Wei Z, Chen S, Zheng J, Li Y
Frontiers in immunology 2024
Comprehensive pan‑cancer analysis of MTDH for human tumor prognosis and as an immunological biomarker including breast and kidney cancer
Yang L, Han M, Zhao X, Zheng L, Kong F, Zhang S, Jia L, Li X, Wang M
Oncology Letters 2024
From monocyte‐derived macrophages to resident macrophages—how metabolism leads their way in cancer
Ammarah U, Pereira\u2010Nunes A, Delfini M, Mazzone M
Molecular Oncology 2024
TRIM59 deficiency promotes M1 macrophage activation and inhibits colorectal cancer through the STAT1 signaling pathway
Wang H, Lou J, Liu H, Liu Y, Xie B, Zhang W, Xie J, Pan H, Han W
Scientific Reports 2024
PIM1/NF-κB/CCL2 blockade enhances anti-PD-1 therapy response by modulating macrophage infiltration and polarization in tumor microenvironment of NSCLC.
Chen X, Zhou J, Wang Y, Wang X, Chen K, Chen Q, Huang D, Jiang R
Oncogene 2024
Neoplastic ICAM-1 protects lung carcinoma from apoptosis through ligation of fibrinogen
Wang S, Wang J, Liu C, Yang L, Tan X, Chen S, Xue Y, Ji H, Ge G, Chen J
Cell Death & Disease 2024
Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironment
Wang H, Yung MM, Xuan Y, Chen F, Chan W, Siu MK, Long R, Jia S, Liang Y, Xu D, Song Z, Tsui SK, Ngan HY, Chan KK, Chan DW
Experimental Hematology & Oncology 2024
Adipocyte derived exosomes promote cell invasion and challenge paclitaxel efficacy in ovarian cancer
Williams ME, Howard D, Donnelly C, Izadi F, Parra JG, Pugh M, Edwards K, Lutchman-Sigh K, Jones S, Margarit L, Francis L, Conlan RS, Taraballi F, Gonzalez D
Cell Communication and Signaling : CCS 2024
Anoikis in cell fate, physiopathology, and therapeutic interventions
Mei J, Jiang X, Tian H, Rong D, Song J, Wang L, Chen Y, Wong RC, Guo C, Wang L, Wang L, Wang P, Yin J
MedComm 2024
Inhalation Anesthetics Play a Janus-Faced Role in Self-Renewal and Differentiation of Stem Cells
Hao X, Li Y, Gao H, Wang Z, Fang B
Biomolecules 2024
High-grade serous ovarian cancer development and anti-PD-1 resistance is driven by IRE1α activity in neutrophils
Emmanuelli A, Salvagno C, Hwang SM, Awasthi D, Sandoval TA, Chae CS, Cheong JG, Tan C, Iwawaki T, Cubillos-Ruiz JR
Oncoimmunology 2024
PTEN loss shapes macrophage dynamics in high grade serous ovarian carcinoma.
Spear S, Le Saux O, Mirza HB, Iyer N, Tyson K, Grundland Freile F, Walton JB, Woodman C, Jarvis S, Ennis DP, Aguirre Hernandez C, Xu Y, Spiliopoulou P, Brenton JD, Costa-Pereira AP, Cook DP, Vanderhyden BC, Keun HC, Triantafyllou E, Arnold JN, McNeish IA
Cancer research 2024
Macrophage diversity in cancer dissemination and metastasis.
Mantovani A, Marchesi F, Di Mitri D, Garlanda C
Cellular & molecular immunology 2024
Beyond tumor-associated macrophages involved in spheroid formation and dissemination: Novel insights for ovarian cancer therapy (Review)
Liu Y, Xiao H, Zeng H, Xiang Y
International Journal of Oncology 2024
Prognostic Significance and Immune Landscape of a Cuproptosis-Related LncRNA Signature in Ovarian Cancer
Zhou M, Tang J, Huang G, Hong L
Biomedicines 2024
Adipose Tissues Have Been Overlooked as Players in Prostate Cancer Progression
Liermann-Wooldrik KT, Kosmacek EA, Oberley-Deegan RE
International Journal of Molecular Sciences 2024
Imaging tumor and ascites-associated macrophages in a mouse model of metastatic ovarian cancer
Foss CA, Wildes F, Mezzanzanica D, Podo F, Hung CF, Yadav S, Vidaver MF
EJNMMI Research 2024
Interactions between ferroptosis and tumour development mechanisms: Implications for gynaecological cancer therapy (Review)
Wu P, Chen J, Li H, Lu H, Li Y, Zhang J
Oncology Reports 2024
Mitophagy in gynecological malignancies: roles, advances, and therapeutic potential
Wang J, Wang D
Cell Death Discovery 2024
Macrophage Checkpoint Nanoimmunotherapy Has the Potential to Reduce Malignant Progression in Bioengineered In Vitro Models of Ovarian Cancer
VandenHeuvel SN, Chau E, Mohapatra A, Dabbiru S, Roy S, O\u2019Connell C, Kamat A, Godin B, Raghavan SA
ACS Applied Bio Materials 2024
Multifaceted cancer alleviation by cowpea mosaic virus in a bioprinted ovarian cancer peritoneal spheroid model
Xiang Y, Zhao Z, Yao EJ, Balayan A, Fiering SN, Steinmetz NF, Chen S
Biomaterials 2024
Targeting lipid metabolism of macrophages: A new strategy for tumor therapy
Shao N, Qiu H, Liu J, Xiao D, Zhao J, Chen C, Wan J, Guo M, Liang G, Zhao X, Xu L
Journal of Advanced Research 2024
Identification of a cancer stem cell-like subpopulation that promotes HCC metastasis
Yang C, Li Y, Wang Z, Shan H, Zhang G, Meng X, Wang G, Hou Z, Zhao X, Zhang X, Liu A, Bing Y, Lei G, Jin Y, Luo J, Guo L, Yin Y
JHEP Reports 2024
Tumor microenvironment in ovarian cancer peritoneal metastasis
Mei S, Chen X, Wang K, Chen Y
Cancer Cell International 2023
Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma
Truxova I, Cibula D, Spisek R, Fucikova J
Journal for ImmunoTherapy of Cancer 2023
Ferroptosis-dependent breast cancer cell-derived exosomes inhibit migration and invasion of breast cancer cells by suppressing M2 macrophage polarization
Yi C, Wu S, Duan Q, Liu L, Li L, Luo Y, Wang A
PeerJ 2023
Insights into high-grade serous carcinoma pathobiology using three-dimensional culture model systems.
Tomas E, Shepherd TG
Journal of Ovarian Research 2023
Revisiting macrophages in ovarian cancer microenvironment: development, function and interaction
El-Arabey AA, Alkhalil SS, Al-Shouli ST, Awadalla ME, Alhamdi HW, Almanaa TN, Mohamed SS, Abdalla M
Medical Oncology 2023
Mouse Tissue-Resident Peritoneal Macrophages in Homeostasis, Repair, Infection, and Tumor Metastasis.
Ardavín C, Alvarez-Ladrón N, Ferriz M, Gutiérrez-González A, Vega-Pérez A
2023
肿瘤微环境中肿瘤相关巨噬细胞极化的影响因素及其意义
GE W, WU W
2023
The generation, activation, and polarization of monocyte-derived macrophages in human malignancies
Chaintreuil P, Kerreneur E, Bourgoin M, Savy C, Favreau C, Robert G, Jacquel A, Auberger P
Frontiers in immunology 2023
Organoids as an Enabler of Precision Immuno-Oncology
Zhao J, Fong A, Seow SV, Toh HC
Cells 2023
Immunological Study of IFN-γ, ICAM-4, and Vitamin D3 Markers among Gastrointestinal Tumor Patients in Babylon Province, Iraq
AL-Shimmery AH, Mahdi ZA, Al-Hindy HA, Al- Mammori RT, Mokif TA, Al-Dahmoshi HO, Al-Khafaji NS
Asian Pacific Journal of Cancer Prevention 2023
Intraperitoneal metastasis of ovarian cancer: new insights on resident macrophages in the peritoneal cavity
Miyamoto T, Murphy B, Zhang N
Frontiers in immunology 2023
Macrophages in immunoregulation and therapeutics.
Chen S, Saeed AFUH, Liu Q, Jiang Q, Xu H, Xiao GG, Rao L, Duo Y
Signal Transduction and Targeted Therapy 2023
A comprehensively prognostic and immunological analysis of chloride intracellular channel protein 5 (CLIC5) in pan-cancer and identification in ovarian cancer.
Huang Q, Lv Q, Tang W, Pan Y, Xing Y, He M, Wu H, Huang J, Huang C, Lan H, Chen J, Xiao G
Journal of Cancer Research and Clinical Oncology 2023
Crosstalk of Immune Cells and Platelets in an Ovarian Cancer Microenvironment and Their Prognostic Significance
Pankowska KA, Będkowska GE, Chociej-Stypułkowska J, Rusak M, Dąbrowska M, Osada J
International journal of molecular sciences 2023
An immune related signature inhibits the occurrence and development of serous ovarian cancer by affecting the abundance of dendritic cells.
Teng F, Wei H, Dong X
Discover. Oncology 2023
VGLL3 expression is associated with macrophage infiltration and predicts poor prognosis in epithelial ovarian cancer
Haque R, Lee J, Chung JY, Shin HY, Kim H, Kim JH, Yun JW, Kang ES
Frontiers in Oncology 2023
“DEPHENCE” system—a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer—a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies
Wilczyński JR, Wilczyński M, Paradowska E
Frontiers in Oncology 2023
Current Understanding on Why Ovarian Cancer Is Resistant to Immune Checkpoint Inhibitors.
Pawłowska A, Rekowska A, Kuryło W, Pańczyszyn A, Kotarski J, Wertel I
International journal of molecular sciences 2023
Myeloid-Derived Suppressor Cells (MDSCs) in Ovarian Cancer—Looking Back and Forward
Okła K
Cells 2023
Pan-cancer analysis of the immune aspects and prognostic value of NCAPG2
Feng H, Chen N, Li H, Zheng Z, Li H, Quan H, Jin X, Jiang P, Wu Q, Yang X
Heliyon 2023
A programmed cell death-related model based on machine learning for predicting prognosis and immunotherapy responses in patients with lung adenocarcinoma
Zhang Y, Wang Y, Chen J, Xia Y, Huang Y
Frontiers in immunology 2023
Metastasis organotropism in colorectal cancer: advancing toward innovative therapies.
He K, Wang Z, Luo M, Li B, Ding N, Li L, He B, Wang H, Cao J, Huang C, Yang J, Chen HN
Journal of Translational Medicine 2023
MicroRNAs Can Influence Ovarian Cancer Progression by Dysregulating Integrin Activity
Fasoulakis Z, Psarommati MZ, Papapanagiotou A, Pergialiotis V, Koutras A, Douligeris A, Mortaki A, Mihail A, Theodora M, Stavros S, Karakalpakis D, Papamihail M, Kontomanolis EN, Daskalakis G, Antsaklis P
Cancers 2023
Multi-omics characteristics of tumor-associated macrophages in the tumor microenvironment of gastric cancer and their exploration of immunotherapy potential
Cao F, Liu Y, Cheng Y, Wang Y, He Y, Xu Y
Scientific Reports 2023
Potential involvement of IL-32 in cell-to-cell communication between macrophages and hepatoblastoma.
Adawy A, Li L, Hirao H, Irie T, Yoshii D, Yano H, Fujiwara Y, Esumi S, Honda M, Suzu S, Komohara Y, Hibi T
Pediatric Surgery International 2023
METTL3-mediated m6A methylation regulates ovarian cancer progression by recruiting myeloid-derived suppressor cells
Wang J, Ling D, Shi L, Li H, Peng M, Wen H, Liu T, Liang R, Lin Y, Wei L, Zhang G, Chen S
Cell & Bioscience 2023
The cross-talk between macrophages and tumor cells as a target for cancer treatment
Aizaz M, Khan A, Khan F, Khan M, Musad Saleh EA, Nisar M, Baran N
Frontiers in Oncology 2023
The expanding Pandora’s toolbox of CD8+T cell: from transcriptional control to metabolic firing
Wu J, Lu Z, Zhao H, Lu M, Gao Q, Che N, Wang J, Ma T
Journal of Translational Medicine 2023
Defining the Role of Metastasis-Initiating Cells in Promoting Carcinogenesis in Ovarian Cancer.
Wang J, Ford JC, Mitra AK
Biology 2023
Roles of tissue-resident immune cells in immunotherapy of non-small cell lung cancer.
Tang R, Wang H, Tang M
Frontiers in immunology 2023
Targeting the immune microenvironment for ovarian cancer therapy.
Blanc-Durand F, Clemence Wei Xian L, Tan DSP
Frontiers in immunology 2023
Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer—The Possibility or the Necessity?
Wilczyński J, Paradowska E, Wilczyński M
Journal of Personalized Medicine 2023
CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype
Wenfeng Zeng, Lixiong Xiong, Wei Wu, Shunrong Li, Jiang Liu, Linbin Yang, Liyan Lao, Mengmeng Zhang, Erwei Song, Jianing Chen, Di Huang
Oncogene 2022
Ovarian Cancer Cells in Ascites Form Aggregates That Display a Hybrid Epithelial-Mesenchymal Phenotype and Allows Survival and Proliferation of Metastasizing Cells
S Capellero, J Erriquez, C Battistini, R Porporato, G Scotto, F Borella, M Renzo, G Valabrega, M Olivero
International journal of molecular sciences 2022
Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies
J Wilczyński, M Wilczyński, E Paradowska
International journal of molecular sciences 2022
Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets
R Czekay, D Cheon, R Samarakoon, S Kutz, P Higgins
Cancers 2022
Principles of dormancy evident in high-grade serous ovarian cancer
T Shepherd, F Dick
Cell division 2022
eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma
Chen X, Wang K, Jiang S, Sun H, Che X, Zhang M, He J, Wen Y, Liao M, Li X, Zhou X, Song J, Ren X, Yi W, Yang J, Chen X, Yin M, Cheng Y
Journal for ImmunoTherapy of Cancer 2022
Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy
Schweer D, McAtee A, Neupane K, Richards C, Ueland F, Kolesar J
Cancers 2022
Spheroid Formation and Peritoneal Metastasis in Ovarian Cancer: The Role of Stromal and Immune Components
Rakina M, Kazakova A, Villert A, Kolomiets L, Larionova I
International journal of molecular sciences 2022
Large-Scale Single-Cell and Bulk Sequencing Analyses Reveal the Prognostic Value and Immune Aspects of CD147 in Pan-Cancer
Zhang J, Wang Z, Zhang X, Dai Z, Zhi-Peng W, Yu J, Peng Y, Wu W, Zhang N, Luo P, Zhang J, Liu Z, Feng S, Zhang H, Cheng Q
Frontiers in immunology 2022
Metastatic Voyage of Ovarian Cancer Cells in Ascites with the Assistance of Various Cellular Components
Uno K, Iyoshi S, Yoshihara M, Kitami K, Mogi K, Fujimoto H, Sugiyama M, Koya Y, Yamakita Y, Nawa A, Kanayama T, Tomita H, Enomoto A, Kajiyama H
International journal of molecular sciences 2022
The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination
Ritch SJ, Telleria CM
Frontiers in Endocrinology 2022
The Outside-In Journey of Tissue Transglutaminase in Cancer
Sima LE, Matei D, Condello S
Cells 2022
Integrated analysis of prognostic immune-related genes in the tumor microenvironment of ovarian cancer
Wang J, Su X, Wang C, Xu M
Annals of translational medicine 2022
Roles and new Insights of Macrophages in the Tumor Microenvironment of Thyroid Cancer
Liu Q, Sun W, Zhang H
Frontiers in pharmacology 2022
A Selective β−Catenin‐Metadherin/CEACAM1‐CCL3 Axis Mediates Metastatic Heterogeneity upon Tumor–Macrophage Interaction
To SK, Tang MK, Tong Y, Zhang J, Chan KK, Ip PP, Shi J, Wong AS
Advanced Science 2022
Tumor Hybrid Cells: Nature and Biological Significance
Tretyakova MS, Subbalakshmi AR, Menyailo ME, Jolly MK, Denisov EV
Frontiers in Cell and Developmental Biology 2022
Targeting CCR2+ macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer
Wu Y, Jennings NB, Sun Y, Dasari SK, Bayraktar E, Corvigno S, Stur E, Glassman D, Mangala LS, Lankenau Ahumada A, Westin SN, Sood AK, Hu W
Journal of Cancer Research and Clinical Oncology 2022
Lipophagy-ICAM-1 pathway associated with fatty acid and oxygen deficiencies is involved in poor prognoses of ovarian clear cell carcinoma.
Koizume S, Takahashi T, Nakamura Y, Yoshihara M, Ota Y, Sato S, Tadokoro H, Yokose T, Kato H, Miyagi E, Miyagi Y
British Journal of Cancer 2022
G-CSF/GM-CSF-induced hematopoietic dysregulation in the progression of solid tumors.
He K, Liu X, Hoffman RD, Shi RZ, Lv GY, Gao JL
FEBS Open Bio 2022
Therapeutic Targeting of Macrophage Plasticity Remodels the Tumor-Immune Microenvironment.
Jang HJ, Lee HS, Yu W, Ramineni M, Truong CY, Ramos D, Splawn T, Choi JM, Jung SY, Lee JS, Wang DY, Sederstrom JM, Pietropaolo M, Kheradmand F, Amos CI, Wheeler TM, Ripley RT, Burt BM
Cancer research 2022
The Good and the Bad: Monocytes’ and Macrophages’ Diverse Functions in Inflammation
Austermann J, Roth J, Barczyk-Kahlert K
Cells 2022
Peritoneal resident macrophages in tumor metastasis and immunotherapy
Zhang Y, Ouyang D, Chen YH, Xia H
Frontiers in Cell and Developmental Biology 2022
Pigment epithelium-derived factor promotes peritoneal dissemination of ovarian cancer through induction of immunosuppressive macrophages.
Ueno S, Sudo T, Saya H, Sugihara E
2022
A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors.
Silk AW, Saraiya B, Groisberg R, Chan N, Spencer K, Girda E, Shih W, Palmeri M, Saunders T, Berman RM, Coric V, Chen S, Zloza A, Vieth J, Mehnert JM, Malhotra J
European Journal of Medical Research 2022
Pan-cancer analysis of the angiotensin II receptor-associated protein as a prognostic and immunological gene predicting immunotherapy responses in pan-cancer
Hong K, Zhang Y, Yao L, Zhang J, Sheng X, Song L, Guo Y, Guo Y
Frontiers in Cell and Developmental Biology 2022
Bioinformatics analysis and identification of genes and pathways involved in patients with Wilms tumor.
Li Y, Tang H, Huang Z, Qin H, Cen Q, Meng F, Huang L, Lin L, Pu J, Yang D
Translational cancer research 2022
Analysis of cell–nanoparticle interactions and imaging of in vitro labeled cells showing barcorded endosomes using fluorescent thiol-organosilica nanoparticles surface-functionalized with polyethyleneimine
Nakamura M, Nakamura J, Mochizuki C, Kuroda C, Kato S, Haruta T, Kakefuda M, Sato S, Tamanoi F, Sugino N
2022
Immune Tumor Microenvironment in Ovarian Cancer Ascites
Almeida-Nunes DL, Mendes-Frias A, Silvestre R, Dinis-Oliveira RJ, Ricardo S
International journal of molecular sciences 2022
Applications of machine learning in tumor-associated macrophages
Li Z, Yu Q, Zhu Q, Yang X, Li Z, Fu J
Frontiers in immunology 2022
Single-cell RNA sequencing uncovers a neuron-like macrophage subset associated with cancer pain.
Tang PC, Chung JY, Liao J, Chan MK, Chan AS, Cheng G, Li C, Huang XR, Ng CS, Lam EW, Zhang D, Ho YP, To KF, Leung KT, Jiang X, Ko H, Lee TL, Lan HY, Tang PM
Science Advances 2022
Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy.
Lin Y, Zhou X, Ni Y, Zhao X, Liang X
Frontiers in immunology 2022
Evolutionary Origins of Metabolic Reprogramming in Cancer.
García-Sancha N, Corchado-Cobos R, Gómez-Vecino A, Jiménez-Navas A, Pérez-Baena MJ, Blanco-Gómez A, Holgado-Madruga M, Mao JH, Cañueto J, Castillo-Lluva S, Mendiburu-Eliçabe M, Pérez-Losada J
International journal of molecular sciences 2022
Isolation of mouse mammary carcinoma-derived macrophages and cancer cells for co-culture assays
Sun L, Han X, Egeblad M
2022
Signatures of EMT, immunosuppression, and inflammation in primary and recurrent human cutaneous squamous cell carcinoma at single-cell resolution.
Li X, Zhao S, Bian X, Zhang L, Lu L, Pei S, Dong L, Shi W, Huang L, Zhang X, Chen M, Chen X, Yin M
Theranostics 2022
Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapy.
Rajtak A, Ostrowska-Leśko M, Żak K, Tarkowski R, Kotarski J, Okła K
Frontiers in immunology 2022
Immune Checkpoint and Other Receptor-Ligand Pairs Modulating Macrophages in Cancer: Present and Prospects
Yang Y, Zhang W, Lan P
Cancers 2022
Modulating the tumor immune microenvironment with nanoparticles: A sword for improving the efficiency of ovarian cancer immunotherapy
Xu T, Liu Z, Huang L, Jing J, Liu X
Frontiers in immunology 2022
Development of the Peritoneal Metastasis: A Review of Back-Grounds, Mechanisms, Treatments and Prospects.
Ren K, Xie X, Min T, Sun T, Wang H, Zhang Y, Dang C, Zhang H
Journal of Clinical Medicine 2022
Tumour-associated macrophages heterogeneity drives resistance to clinical therapy
Guo S, Chen X, Guo C, Wang W
Expert Reviews in Molecular Medicine 2022
RBM10 Is a Biomarker Associated with Pan-Cancer Prognosis and Immune Infiltration: System Analysis Combined with In Vitro and Vivo Experiments
Cao Y, Pang L, Jin S
Oxidative Medicine and Cellular Longevity 2022
The liver metastatic niche: modelling the extracellular matrix in metastasis
J Drew, LM Machesky
Disease models & mechanisms 2021
Ovarian Cancer: Molecular & Diagnostic Imaging and Treatment Strategies
H Schatten
2021
Ovarian Cancer: Molecular & Diagnostic Imaging and Treatment Strategies
H Schatten
2021
Exploring the clinical value of tumor microenvironment in platinum-resistant ovarian cancer
A Ghoneum, S Almousa, B Warren, AY Abdulfattah, J Shu, H Abouelfadl, D Gonzalez, C Livingston, N Said
Seminars in Cancer Biology 2021
Molecular and cellular mechanisms controlling integrin-mediated cell adhesion and tumor progression in ovarian cancer metastasis: a review
D Dhaliwal, TG Shepherd
Clinical & Experimental Metastasis 2021
Immunological configuration of ovarian carcinoma: features and impact on disease outcome
J Fucikova, A Coosemans, S Orsulic, D Cibula, I Vergote, L Galluzzi, R Spisek
Journal for ImmunoTherapy of Cancer 2021
The Complement System in Ovarian Cancer: An Underexplored Old Path
Y Senent, D Ajona, A González-Martín, R Pio, B Tavira
Cancers 2021
The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure
C Galassi, M Musella, N Manduca, E Maccafeo, A Sistigu
Cells 2021
Tumor-associated macrophages induced spheroid formation by CCL18-ZEB1-M-CSF feedback loop to promote transcoelomic metastasis of ovarian cancer
L Long, Y Hu, T Long, X Lu, Y Tuo, Y Li, Z Ke
Journal for ImmunoTherapy of Cancer 2021
Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor—Glioma Therapy?
N Tong, Z He, Y Ma, Z Wang, Z Huang, H Cao, L Xu, Y Zou, W Wang, C Yi, Z Yin, Q Wang
Frontiers in Cell and Developmental Biology 2021
CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion
G Gunaydin
Frontiers in Oncology 2021
Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response
BP Rickard, C Conrad, AJ Sorrin, MK Ruhi, JC Reader, SA Huang, W Franco, G Scarcelli, WJ Polacheck, DM Roque, MG del Carmen, HC Huang, U Demirci, I Rizvi
Cancers 2021
Tumor-Associated Macrophages: New Horizons for Pituitary Adenoma Researches
C Han, S Lin, X Lu, L Xue, ZB Wu
Frontiers in Endocrinology 2021
Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives
BA Maiorano, MF Maiorano, D Lorusso, E Maiello
Cancers 2021
circRNAs: Insight Into Their Role in Tumor-Associated Macrophages
S Duan, S Wang, T Huang, J Wang, X Yuan
Frontiers in Oncology 2021
Downregulation of hsa_circ_0074854 Suppresses the Migration and Invasion in Hepatocellular Carcinoma via Interacting with HuR and via Suppressing Exosomes-Mediated Macrophage M2 Polarization
Y Wang, R Gao, J Li, S Tang, S Li, Q Tong, S Li
International Journal of Nanomedicine 2021
Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers
T Xu, S Yu, J Zhang, S Wu
Journal of Hematology & Oncology 2021
ALOX5AP Predicts Poor Prognosis by Enhancing M2 Macrophages Polarization and Immunosuppression in Serous Ovarian Cancer Microenvironment
X Ye, L An, X Wang, C Zhang, W Huang, C Sun, R Li, H Ma, H Wang, M Gao
Frontiers in Oncology 2021
Molecular characteristics and tumorigenicity of ascites‐derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer
Y Ding, V Labitzky, K Legler, M Qi, U Schumacher, B Schmalfeldt, C Stürken, L OliveiraFerrer
Molecular Oncology 2021
Role of macrophage in nanomedicine-based disease treatment
S Song, H Xia, M Guo, S Wang, S Zhang, P Ma, Y Jin
Drug Delivery 2021
Immunology and Immune Checkpoint Inhibition in Ovarian Cancer – Current Aspects
H Bronger
Geburtshilfe und Frauenheilkunde 2021
Tumor-associated macrophages promote pancreatic ductal adenocarcinoma progression by inducing epithelial-to-mesenchymal transition
C Xiong, Y Zhu, M Xue, Y Jiang, Y Zhong, L Jiang, M Shi, H Chen
Aging 2021
The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression
H Wang, MM Yung, HY Ngan, KK Chan, DW Chan
International journal of molecular sciences 2021
Exosomes and organ-specific metastasis
L Zhao, X Ma, J Yu
Molecular Therapy — Methods & Clinical Development 2021
Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives
U Mehraj, H Qayoom, MA Mir
Breast Cancer 2021
Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer
M Zheng, J Long, A Chelariu-Raicu, H Mullikin, T Vilsmaier, A Vattai, HH Heidegger, F Batz, S Keckstein, U Jeschke, F Trillsch, S Mahner, T Kaltofen
Cancers 2021
Systematic analysis of the relationship between ovarian cancer prognosis and alternative splicing
D Zhang, D Zou, Y Deng, L Yang
Journal of Ovarian Research 2021
Activating a collaborative innate-adaptive immune response to control metastasis
L Sun, T Kees, A Almeida, B Liu, X He, D Ng, X Han, D Spector, I McNeish, P Gimotty, S Adams, M Egeblad
Cancer Cell 2021
Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment
M Neganova, J Liu, Y Aleksandrova, S Klochkov, R Fan
Cancers 2021
Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment
G Shi, P Shi, Y Yu, J Xu, J Ma, Y Zhang, Z Dong, L Shen, L Dai, L Cheng, P Cheng, H Deng
Molecular Therapy — Oncolytics 2021
Smad3 Promotes Cancer‐Associated Fibroblasts Generation via Macrophage–Myofibroblast Transition
PC Tang, JY Chung, VW Xue, J Xiao, XM Meng, XR Huang, S Zhou, AS Chan, AC Tsang, AS Cheng, TL Lee, KT Leung, EW Lam, KF To, PM Tang, HY Lan
Advanced Science 2021
Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies
S Zhu, M Yi, Y Wu, B Dong, K Wu
Experimental Hematology and Oncology 2021
Allogeneic human neural stem cells for improved therapeutic delivery to peritoneal ovarian cancer
Mooney R, Abidi W, Batalla-Covello J, Ngai HW, Hyde C, Machado D, Abdul-Majid A, Kang Y, Hammad M, Flores L, Copeland G, Dellinger T, Han E, Berlin J, Aboody KS
Stem Cell Research & Therapy 2021
A novel ferroptosis related gene signature is associated with prognosis in patients with ovarian serous cystadenocarcinoma
Yu Z, He H, Chen Y, Ji Q, Sun M
Scientific Reports 2021
Preoperative LMR and Serum CA125 Level as Risk Factors for Advanced Stage of Ovarian Cancer
Tang Y, Hu HQ, Tang YL, Tang FX, Zheng XM, Deng LH, Yang MT, Yin S, Li J, Xu F
Journal of Cancer 2021
Integrated analysis of tumor-associated macrophage infiltration and prognosis in ovarian cancer
Tan Q, Liu H, Xu J, Mo Y, Dai F
Aging 2021
An Immune-Related Gene-Based Signature as Prognostic Tool in Ovarian Serous Cystadenocarcinoma
Shi F, Deng T, Mo J, Wang H, Lu J
International journal of general medicine 2021
FPR2 participates in epithelial ovarian cancer (EOC) progression through RhoA-mediated M2 macrophage polarization
Xie X, He J, Wang Q, Liu Y, Chen W, Shi K
Journal of Ovarian Research 2021
Lymphocyte and macrophage infiltration in omental metastases indicates poor prognosis in advance stage epithelial ovarian cancer
Zhang T, Liu Q, Zhu Y, Huang Y, Qin J, Wu X, Zhang S
2021
TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK pathway.
Wei X, Lou H, Zhou D, Jia Y, Li H, Huang Q, Ma J, Yang Z, Sun C, Meng Y, Xu S, Yang X, Li X, Ji T, Guo Z, Gao Q
Journal of experimental & clinical cancer research : CR 2021
Macrophages in ovarian cancer and their interactions with monoclonal antibody therapies
Osborn G, Stavraka C, Adams R, Sayasneh A, Ghosh S, Montes A, Lacy KE, Kristeleit R, Spicer J, Josephs DH, Arnold JN, Karagiannis SN
Clinical & Experimental Immunology 2021
Autophagic adaptation to oxidative stress alters peritoneal residential macrophage survival and ovarian cancer metastasis
Houjun Xia, Shasha Li, Xiong Li, Weichao Wang, Yingjie Bian, Shuang Wei, Sara Grove, Weimin Wang, Linda Vatan, J. Rebecca Liu, Karen McLean, Ramandeep Rattan, Adnan R. Munkarah, Jun-Lin Guan, Ilona Kryczek, Weiping Zou
JCI Insight 2020
M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer
M Hensler, L Kasikova, K Fiser, J Rakova, P Skapa, J Laco, T Lanickova, L Pecen, I Truxova, S Vosahlikova, I Moserova, I Praznovec, V Drochytek, M Rehackova, T Brtnicky, L Rob, V Benes, J Pistolic, L Sojka, A Ryska, C Sautes-Fridman, WH Fridman, L Galluzzi, R Spisek, J Fucikova
Journal for ImmunoTherapy of Cancer 2020
Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages
M Song, OO Yeku, S Rafiq, T Purdon, X Dong, L Zhu, T Zhang, H Wang, Z Yu, J Mai, H Shen, B Nixon, M Li, RJ Brentjens, X Ma
Nature Communications 2020
Targeting Tumor-Associated Macrophages by MMP2-Sensitive Apoptotic Body-Mimicking Nanoparticles
Y Liu, J Wang, J Zhang, S Marbach, W Xu, L Zhu
ACS Applied Materials & Interfaces 2020
Vitamin C Inhibits Metastasis of Peritoneal Tumors By Preventing Spheroid Formation in ID8 Murine Epithelial Peritoneal Cancer Model
Y Xu, X Guo, G Wang, C Zhou
Frontiers in pharmacology 2020
Tumor Microenvironment in Ovarian Cancer: Function and Therapeutic Strategy
Y Yang, Y Yang, J Yang, X Zhao, X Wei
Frontiers in Cell and Developmental Biology 2020
Molecular mediators of peritoneal metastasis in pancreatic cancer
LR Avula, B Hagerty, C Alewine
Cancer and Metastasis Reviews 2020
The influence of secreted factors and extracellular vesicles in ovarian cancer metastasis
M Hergueta-Redondo, H Peinado
European Journal of Cancer Supplements 2020
CD44 in Ovarian Cancer Progression and Therapy Resistance—A Critical Role for STAT3
A Martincuks, PC Li, Q Zhao, C Zhang, YJ Li, H Yu, L Rodriguez-Rodriguez
Frontiers in Oncology 2020
Preclinical and Clinical Immunotherapeutic Strategies in Epithelial Ovarian Cancer
A Martinez, JP Delord, M Ayyoub, C Devaud
Cancers 2020
The omentum, a niche for premetastatic ovarian cancer
X Ma
Journal of Experimental Medicine 2020
Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
C Yang, BR Xia, ZC Zhang, YJ Zhang, G Lou, WL Jin
Frontiers in immunology 2020
Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer
S Muñoz-Galván, A Carnero
Cells 2020
Tumor-Associated Macrophages in Tumor Immunity
Y Pan, Y Yu, X Wang, T Zhang
Frontiers in immunology 2020
Macrophages: an indispensable piece of ovarian health
Z Zhang, L Huang, L Brayboy
Biology of reproduction 2020
Impact of anatomic site on antigen-presenting cells in cancer
M Zagorulya, E Duong, S Spranger
Journal for ImmunoTherapy of Cancer 2020
Lysophosphatidic acid modulates ovarian cancer multicellular aggregate assembly and metastatic dissemination
Y Klymenko, B Bos, L Campbell, E Loughran, Y Liu, J Yang, O Kim, MS Stack
Scientific Reports 2020
Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
I Larionova, G Tuguzbaeva, A Ponomaryova, M Stakheyeva, N Cherdyntseva, V Pavlov, E Choinzonov, J Kzhyshkowska
Frontiers in Oncology 2020

The Role of Exosomes in the Female Reproductive System and Breast Cancers


Y Bai, J Guo, Z Liu, Y Li, S Jin, T Wang
OncoTargets and therapy 2020

CTHRC1 in Ovarian Cancer Promotes M2-Like Polarization of Tumor-Associated Macrophages via Regulation of the STAT6 Signaling Pathway


Y Bai, K Yin, T Su, F Ji, S Zhang
OncoTargets and therapy 2020
Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction
M Yin, Y Guo, R Hu, WL Cai, Y Li, S Pei, H Sun, C Peng, J Li, R Ye, Q Yang, N Wang, Y Tao, X Chen, Q Yan
Nature Communications 2020
Construction of a novel prognostic-predicting model correlated to ovarian cancer
W Tang, J Li, X Chang, L Jia, Q Tang, Y Wang, Y Zheng, L Sun, Z Feng
Bioscience Reports 2020
Organotypic Modeling of the Tumor Landscape
MM Haykal, C Nahmias, C Varon, OC Martin
Frontiers in Cell and Developmental Biology 2020
Specific targeting of ovarian tumor-associated macrophages by large, anionic nanoparticles
T Haber, YR Cornejo, S Aramburo, L Flores, P Cao, A Liu, R Mooney, M Gilchrist, R Tirughana, U Nwokafor, W Abidi, E Han, T Dellinger, MT Wakabayashi, KS Aboody, JM Berlin
Proceedings of the National Academy of Sciences 2020
STAT3 signaling in ovarian cancer: a potential therapeutic target
Liang R, Chen X, Chen L, Wan F, Chen K, Sun Y, Zhu X
Journal of Cancer 2020
Three Genes Predict Prognosis in Microenvironment of Ovarian Cancer
Guo Y, Wang YL, Su WH, Yang PT, Chen J, Luo H
Frontiers in Genetics 2020
Seven-Gene Signature Based on Glycolysis Is Closely Related to the Prognosis and Tumor Immune Infiltration of Patients With Gastric Cancer
Yu S, Hu C, Cai L, Du X, Lin F, Yu Q, Liu L, Zhang C, Liu X, Li W, Zhan Y
Frontiers in Oncology 2020
Natural and Synthetic Biomaterials for Engineering Multicellular Tumor Spheroids
Kamatar A, Gunay G, Acar H
Polymers 2020
BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages
Li X, Fu Y, Yang B, Guo E, Wu Y, Huang J, Zhang X, Xiao R, Li K, Wang B, Hu J, Sun C, Chen G
Frontiers in immunology 2020
Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients.
Macciò A, Gramignano G, Cherchi MC, Tanca L, Melis L, Madeddu C
Scientific Reports 2020
The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer.
Nowak M, Klink M
Cells 2020
The hallmarks of ovarian cancer: Focus on angiogenesis and micro-environment and new models for their characterisation
Heredia-Soto V, López-Guerrero JA, Redondo A, Mendiola M
EJC Supplements 2020
Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity
CJ Wu, V Sundararajan, BC Sheu, RY Huang, LH Wei
Cancers 2019
Ovarian Cancer Dissemination—A Cell Biologist’s Perspective
S Farsinejad, T Cattabiani, T Muranen, M Iwanicki
Cancers 2019

Tumor-Associated Macrophages (TAMs): A Critical Activator In Ovarian Cancer Metastasis


M Yin, J Shen, S Yu, J Fei, X Zhu, J Zhao, L Zhai, A Sadhukhan, J Zhou
OncoTargets and therapy 2019
Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis
HA Kenny, M Lal-Nag, M Shen, B Kara, DA Nahotko, K Wroblewski, S Fazal, S Chen, CY Chiang, YJ Chen, KR Brimacombe, J Marugan, M Ferrer, E Lengyel
Molecular cancer therapeutics 2019
Ovarian Cancer Stemness: Biological and Clinical Implications for Metastasis and Chemotherapy Resistance
T Motohara, H Katabuchi
Cancers 2019
Integrated cancer tissue engineering models for precision medicine
ME Bregenzer, EN Horst, P Mehta, CM Novak, S Raghavan, CS Snyder, G Mehta, N Cameron
PloS one 2019
Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer
Q Gao, Z Yang, S Xu, X Li, X Yang, P Jin, Y Liu, X Zhou, T Zhang, C Gong, X Wei, D Liu, C Sun, G Chen, J Hu, L Meng, J Zhou, K Sawada, R Fruscio, TW Grunt, J Wischhusen, VM Vargas-Hernández, B Pothuri, RL Coleman
Journal of Experimental Medicine 2019
Exosomes promote pre-metastatic niche formation in ovarian cancer
W Feng, DC Dean, FJ Hornicek, H Shi, Z Duan
Molecular Cancer 2019
CD34+KLF4+ Stromal Stem Cells Contribute to Endometrial Regeneration and Repair
M Yin, HJ Zhou, C Lin, L Long, X Yang, H Zhang, H Taylor, W Min
Cell Reports 2019
Genistein inhibits stemness of SKOV3 cells induced by macrophages co-cultured with ovarian cancer stem-like cells through IL-8/STAT3 axis
Y Ning, W Feng, X Cao, K Ren, M Quan, A Chen, C Xu, Y Qiu, J Cao, X Li, X Luo
Journal of Experimental & Clinical Cancer Research 2019
Fibroblasts: Dangerous travel companions
H Schreiber
Journal of Experimental Medicine 2019
The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication
RD Nola, A Menga, A Castegna, V Loizzi, G Ranieri, E Cicinelli, G Cormio
International journal of molecular sciences 2019
Novel strategy of ovarian cancer implantation: Pre‐invasive growth of fibrin‐anchored cells with neovascularization
A Matsuoka, Y Mizumoto, M Ono, K Kagami, T Obata, J Terakawa, Y Maida, M Nakamura, T Daikoku, H Fujiwara
Cancer Science 2019
Improved Anti-Tumor Efficacy of Paclitaxel in Combination with MicroRNA-125b-based Tumor-Associated Macrophage Repolarization in Epithelial Ovarian Cancer
Parayath NN, Gandham SK, Leslie F, Amiji MM
Cancer Letters 2019
M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression
Zeng XY, Xie H, Yuan J, Jiang XY, Yong JH, Zeng D, Dou YY, Xiao SS
Cancer biology & therapy 2019
Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments
Raghavan S, Mehta P, Xie Y, Lei YL, Mehta G
Journal for ImmunoTherapy of Cancer 2019
Alternatively activated macrophage-derived secretome stimulates ovarian cancer spheroid spreading through a JAK2/STAT3 pathway
Fogg KC, Olson WR, Miller JN, Khan A, Renner C, Hale I, Weisman PS, Kreeger PK
Cancer Letters 2019
Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer
SA Habyan, C Kalos, J Szymborski, L McCaffrey
Oncogene 2018
The oncogene KRAS promotes cancer cell dissemination by stabilizing spheroid formation via the MEK pathway
J Ogishima, A Taguchi, A Kawata, K Kawana, M Yoshida, Y Yoshimatsu, M Sato, H Nakamura, Y Kawata, A Nishijima, A Fujimoto, K Tomio, K Adachi, T Nagamatsu, K Oda, T Kiyono, Y Osuga, T Fujii
BMC Cancer 2018
The versatile role of exosomes in cancer progression: diagnostic and therapeutic implications
V Sundararajan, FH Sarkar, TS Ramasamy
Cellular Oncology 2018
An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment
T Motohara, K Masuda, M Morotti, Y Zheng, S El-Sahhar, KY Chong, N Wietek, A Alsaadi, M Karaminejadranjbar, Z Hu, M Artibani, LS Gonzalez, H Katabuchi, H Saya, AA Ahmed
Oncogene 2018
KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation: Epithelial-macrophage interaction in pancreas cancer
F Bishehsari, L Zhang, U Barlass, NZ Preite, S Turturro, MS Najor, BB Shetuni, JP Zayas, M Mahdavinia, AM Abukhdeir, A Keshavarzian
International Journal of Cancer 2018
Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment
ML Drakes, PJ Stiff
Cancers 2018
Targeting the Microenvironment in High Grade Serous Ovarian Cancer
N Nwani, L Sima, W Nieves-Neira, D Matei
Cancers 2018
Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy
V Gupta, F Yull, D Khabele
Cancers 2018
Malignant peritoneal effusion acting as a tumor environment in ovarian cancer progression: Impact and significance
A Piché
World journal of clinical oncology 2018
Krüppel like factor 6 splice variant 1 (KLF6-SV1) overexpression recruits macrophages to participate in lung cancer metastasis by up-regulating TWIST1
J Wang, X Wang, Y Wang, S Li, X Wang
Cancer biology & therapy 2018
Tumor evolution and chemoresistance in ovarian cancer
S Kim, Y Han, SI Kim, HS Kim, SJ Kim, YS Song
npj Precision Oncology 2018
Evaluating Tumor Evolution via Genomic Profiling of Individual Tumor Spheroids in a Malignant Ascites
S Kim, S Kim, J Kim, B Kim, SI Kim, MA Kim, S Kwon, YS Song
Scientific Reports 2018
Cross-talk between ovarian cancer cells and macrophages through periostin promotes macrophage recruitment
M Tang, B Liu, X Bu, P Zhao
Cancer Science 2018
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors
C Li, E Bonazzoli, S Bellone, J Choi, W Dong, G Menderes, G Altwerger, C Han, A Manzano, A Bianchi, F Pettinella, P Manara, S Lopez, G Yadav, F Riccio, L Zammataro, B Zeybek, Y Yang-Hartwich, N Buza, P Hui, S Wong, A Ravaggi, E Bignotti, C Romani, P Todeschini, L Zanotti, V Zizioli, F Odicino, S Pecorelli, L Ardighieri, DA Silasi, B Litkouhi, E Ratner, M Azodi, GS Huang, PE Schwartz, RP Lifton, J Schlessinger, AD Santin
Proceedings of the National Academy of Sciences 2018
Novel therapeutic strategies for advanced ovarian cancer by using induced pluripotent stem cell‐derived myelomonocytic cells producing interferon beta
Imamura Y, Tashiro H, Tsend\u2010Ayush G, Haruta M, Dashdemberel N, Komohara Y, Tsuboki J, Takaishi K, Ohba T, Nishimura Y, Katabuchi H, Senju S
Cancer Science 2018
3D Co-culture System of Tumor-associated Macrophages and Ovarian Cancer Cells
Long L, Yin M, Min AW
Bio-protocol 2018
ASK1-dependent endothelial cell activation is a critical in ovarian cancer growth and metastasis
Mingzhu Yin, Huanjiao Zhou, Jiqin Zhang, Caixia Lin, Hongmei Li, Xia Li, Yonghao Li, Haifeng Zhang, David Breckenridge, Weidong Ji, Wang Min
JCI Insight 2017
CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors
IM Min, E Shevlin, Y Vedvyas, M Zaman, B Wyrwas, T Scognamiglio, MD Moore, W Wang, S Park, S Park, S Panjwani, KD Gray, AB Tassler, R Zarnegar, TJ Fahey, MM Jin
Clinical cancer research 2017
Role of LFA-1 and ICAM-1 in Cancer
M Reina, E Espel
Cancers 2017
Tumor‐associated macrophages (TAMs) depend on ZEB1 for their cancer‐promoting roles
M Cortés, L SanchezMoral, O Barrios, MJ FernándezAceñero, MC MartínezCampanario, A EsteveCodina, DS Darling, B Győrffy, T Lawrence, DC Dean, A Postigo
The EMBO Journal 2017
The peritoneal “soil” for a cancerous “seed”: a comprehensive review of the pathogenesis of intraperitoneal cancer metastases
J Mikuła-Pietrasik, P Uruski, A Tykarski, K Książek
Cellular and Molecular Life Sciences 2017
Cross-talk mechanism between endothelial cells and hepatocellular carcinoma cells via growth factors and integrin pathway promotes tumor angiogenesis and cell migration
T Feng, H Yu, Q Xia, Y Ma, H Yin, Y Shen, X Liu
Oncotarget 2017
TAMeless traitors: macrophages in cancer progression and metastasis
S Aras, MR Zaidi
British Journal of Cancer 2017
siRNA-mediated knockdown of ID1 disrupts Nanog- and Oct-4-mediated cancer stem cell-likeness and resistance to chemotherapy in gastric cancer cells
L Li, X Wei, B Wu, Y Xiao, M Yin, Q Yang
Oncology Letters 2017
B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activity
SJ McKee, ZK Tuong, T Kobayashi, BL Doff, MS Soon, M Nissen, PY Lam, C Keane, F Vari, D Moi, R Mazzieri, G Leggatt, MK Gandhi, SR Mattarollo
OncoImmunology 2017
Immune Cell Population in Ovarian Tumor Microenvironment
Cai DL, Jin LP
Journal of Cancer 2017
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 … 9 10 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 5 news outlets
Blogged by 1
Posted by 34 X users
Referenced in 1 patents
On 2 Facebook pages
239 readers on Mendeley
See more details